{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:03:48Z","timestamp":1792091028829,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcf.2020.11.020","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:44:09Z","timestamp":1608165849000},"page":"288-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation"],"prefix":"10.1016","volume":"20","author":[{"given":"E. Emily","family":"Harruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela Tupayachi","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dorgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Poth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jin M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela G.","family":"Shoup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcf.2020.11.020_bib0001","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jcf.2020.11.020_bib0002","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-4274(90)90033-I","article-title":"Aminoglycoside-induced ototoxicity","volume":"52","author":"Govaerts","year":"1990","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jcf.2020.11.020_bib0003","series-title":"Audiologic management of individuals receiving cochleotoxic drug therapy [Guidelines]","year":"1994"},{"key":"10.1016\/j.jcf.2020.11.020_bib0004","series-title":"Position statement and clinical practice guidelines: Ototoxicity monitoring","year":"2009"},{"key":"10.1016\/j.jcf.2020.11.020_bib0005","series-title":"Evidence-based systematic review (EBSR): Drug-induced hearing loss\u2014aminoglycosides","author":"Frymark","year":"2010"},{"issue":"4","key":"10.1016\/j.jcf.2020.11.020_bib0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.31.4.594","article-title":"Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis","volume":"31","author":"Pedersen","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcf.2020.11.020_bib0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/149.2.257","article-title":"Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis","volume":"149","author":"Tablan","year":"1984","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcf.2020.11.020_bib0008","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/00016480903015150","article-title":"No hearing loss after repeated courses of tobramycin in cystic fibrosis patients","volume":"130","author":"Scheenstra","year":"2010","journal-title":"Acta Otolaryngol."},{"issue":"9","key":"10.1016\/j.jcf.2020.11.020_bib0009","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcf.2020.11.020_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2014","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.jcf.2020.11.020_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcf.2017.01.006","article-title":"The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis","volume":"16","author":"Garinis","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"7","key":"10.1016\/j.jcf.2020.11.020_bib0012","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00995-05","article-title":"Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients","volume":"50","author":"Mulheran","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jcf.2020.11.020_bib0013","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/14992027.2010.524253","article-title":"Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: a study using extended high-frequency audiometry and distortion product otoacoustic emissions","volume":"50","author":"Al-Malky","year":"2011","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.jcf.2020.11.020_bib0014","series-title":"Stop ototoxicity: phase 1\/2 clinical trial of SPI-1005 in cystic fibrosisNorth American Cystic Fibrosis Conference, Denver, CO","author":"Kil","year":"2018"},{"key":"10.1016\/j.jcf.2020.11.020_bib0015","series-title":"Stop ototoxicity: phase 1\/2 clinical trial of SPI-1005 in cystic fibrosisAssociation for Research in Otolaryngology Annual Midwinter Meeting, Baltimore, MD","author":"Kil","year":"2019"},{"issue":"8","key":"10.1016\/j.jcf.2020.11.020_bib0016","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0040-1715935","article-title":"Early detection of ototoxicity using 1\/6th-octave steps","volume":"14","author":"Fausti","year":"2003","journal-title":"J. Am. Acad. Audiol."},{"issue":"6","key":"10.1016\/j.jcf.2020.11.020_bib0017","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1682\/JRRD.2005.01.0009","article-title":"Use of 35 words for evaluation of hearing loss in signal-to-babble ratio: a clinic protocol","volume":"42","author":"Wilson","year":"2005","journal-title":"J. Rehabil. Res. Dev."},{"issue":"2","key":"10.1016\/j.jcf.2020.11.020_bib0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/AUD.0b013e31822f67c0","article-title":"The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus","volume":"33","author":"Meikle","year":"2012","journal-title":"Ear Hear."},{"issue":"8","key":"10.1016\/j.jcf.2020.11.020_bib0019","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7326\/0003-4819-141-8-200410190-00007","article-title":"Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness","volume":"141","author":"Yardley","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.jcf.2020.11.020_bib0020","first-page":"493","article-title":"Uses and abuses of hearing loss classification","volume":"23","author":"Clark","year":"1981","journal-title":"ASHA"},{"issue":"12","key":"10.1016\/j.jcf.2020.11.020_bib0021","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14992027.2018.1514537","article-title":"Negative hearing effects of a single course of IV aminoglycoside therapy in cystic fibrosis patients","volume":"57","author":"Gleser","year":"2018","journal-title":"Int. J. Audiol."},{"issue":"4","key":"10.1016\/j.jcf.2020.11.020_bib0022","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bjorl.2016.10.006","article-title":"Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review","volume":"83","author":"Caumo","year":"2017","journal-title":"Braz J. Otorhinolaryngol."},{"key":"10.1016\/j.jcf.2020.11.020_bib0023","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1999.tb08636.x","article-title":"Acute and chronic effects of aminoglycosides on cochlear hair cells","volume":"884","author":"Aran","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jcf.2020.11.020_bib0024","article-title":"Ebselen attenuates tobramycin-induced ototoxicity in mice","author":"Gu","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2020.11.020_bib0025","article-title":"Amikacin treatment leads to hyperacusis and tinnitus in the absence of significant hearing loss","author":"Longenecker","year":"2020","journal-title":"Front. Neurosci."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320309309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320309309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:43:56Z","timestamp":1761601436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320309309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1569199320309309"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.11.020","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}